DaVita, Inc. (NYSE:DVA)

CAPS Rating: 3 out of 5

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.

Results 21 - 25 of 25 : « Previous 1 2

Recs

0
Member Avatar Rimvydas (< 20) Submitted: 10/6/2006 2:06:21 PM : Outperform Start Price: $58.53 DVA Score: +35.37

The largest kiddney dialysis network in US. Has the market locked up.

Recs

0
Member Avatar whodde2006 (56.79) Submitted: 9/14/2006 9:50:03 PM : Outperform Start Price: $58.35 DVA Score: +34.25

POPULATION IS GETTING OLDER, FATTER, AND MORE DIABETIC. THIS WILL NECESSITATE THE NEED FOR MORE KIDNEY DIALYSIS.

Recs

0
Member Avatar buckpower (89.00) Submitted: 8/29/2006 12:22:54 AM : Outperform Start Price: $58.88 DVA Score: +30.95

diabetes is a problem in the US and they help those with diabetes

Recs

0
Member Avatar tekmanr (63.59) Submitted: 8/26/2006 10:26:47 PM : Outperform Start Price: $57.81 DVA Score: +32.82

High Relative Strength.

Recs

1
Member Avatar OSUChad (96.86) Submitted: 8/25/2006 6:22:57 AM : Outperform Start Price: $57.15 DVA Score: +34.38

Davita - value

Results 21 - 25 of 25 : « Previous 1 2

Featured Broker Partners


Advertisement